#news #biotech Eli Lilly kickstarts speedy FDA review for Alzheimer’s hopeful donanemab—and a one-on-one test against Aduhelm

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Eli Lilly kickstarts speedy FDA review for Alzheimer’s hopeful donanemab—and a one-on-one test against Aduhelm .Eli Lilly kickstarts speedy FDA review for Alzheimer’s hopeful donanemab—and a one-on-one test against Aduhelm
badams
Tue, 10/26/2021 – 06:59

from FierceBiotech: Biotech https://ift.tt/3berCMO